1 – 10 of 53
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B
2024) In Haemophilia(
- Contribution to journal › Article
- 2023
-
Mark
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B : post hoc analysis of phase III trials using patient-reported outcomes
(
- Contribution to journal › Article
- 2022
-
Mark
rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B : Post hoc analysis of B-LONG using haemophilia-specific quality of life questionnaires
(
- Contribution to journal › Article
- 2018
-
Mark
How I manage patients with inherited haemophilia A and B and factor inhibitors
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Primary prophylaxis in haemophilia care : Guideline update 2016
(
- Contribution to journal › Article
-
Mark
European retrospective study of real-life haemophilia treatment
(
- Contribution to journal › Article
-
Mark
Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment
(
- Contribution to journal › Article
- 2016
-
Mark
Future of haemophilia outcome assessment : Registries are key to optimized treatment
(
- Contribution to journal › Article
-
Mark
Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits : A two-center study
(
- Contribution to journal › Article
-
Mark
Prophylaxis for Hemophilia in the Era of Extended Half-Life Factor VIII/Factor IX Products
(
- Contribution to journal › Article